
A comprehensive genetic analysis covering both coding and non-coding regions for a holistic view of the genome.

Testing for mutations associated with increased risks of breast and ovarian cancers.

Focusing on all protein-coding genes, WES captures the most important regions of the genome, identifying about 85% of disease-related variants.

Confirming biological relationships between individuals.

A safe and reliable way to assess fetal risk for genetic disorders.

For confirmation of genetic mutations detected by other methods.

Identifying carriers of genetic disorders to help families assess the risk of passing on conditions.

Expert guidance in test selection, result interpretation, and patient management.